Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  • Equipment

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  • Equipment
  1. Outputs

Using [18F]FDG PET/CT to Identify Optimal Responders to Neoadjuvant Therapy in Breast Cancer—Results from a Prospective Patient Cohort

Academic Article
Publication Date:
2025
Short description:
Using [18F]FDG PET/CT to Identify Optimal Responders to Neoadjuvant Therapy in Breast Cancer—Results from a Prospective Patient Cohort / Gelardi, F., Tiberio, P., Torrisi, R., Zanca, R., Rodari, M., Zambelli, A., Santoro, A., Fernandes, B., Sagona, A., Errico, V., Testori, A., Tinterri, C., Chiti, A., De Sanctis, R., Sollini, M., Antunovic, L.. - In: CANCERS. - ISSN 2072-6694. - 17:13(2025). [10.3390/cancers17132133]
abstract:
Background/objectives: Pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer (BC) is a solid indicator of favourable prognosis, potentially also being useful for more conservative patient management. We aim to explore the potential of [18F]FDG PET/CT as a non-invasive method to predict response to NAC. Methods: In this prospective, observational cohort study, we enrolled BC patient candidates for NAC who underwent baseline and preoperative [18F]FDG PET/CT. NAC response was determined using final histopathology. PET images were assessed qualitatively and semi-quantitatively, and the findings correlated with NAC response. Results: In total, 133 BC patients were included. The visual analysis of preoperative PET/CT detected residual disease (RD) with high specificity (>93%) and moderate sensitivity, based on pCR/RD classification and RCB index. Semiquantitative measures (SUVmax, TBR) were significantly higher in non-responders across the classification methods (p < 0.001 for all). Conclusions: These findings highlight the potential of preoperative [18F]FDG PET/CT as a complementary tool for identifying excellent responders to NAC across BC subtypes or response criteria. This could inform personalised treatment and potentially allow for surgery to be omitted in selected patients.
Iris type:
1.1 Articolo in rivista
List of contributors:
Gelardi, Fabrizia; Tiberio, Paola; Torrisi, Rosalba; Zanca, Roberta; Rodari, Marcello; Zambelli, Alberto; Santoro, Armando; Fernandes, Bethania; Sagona, Andrea; Errico, Valentina; Testori, Alberto; Tinterri, Corrado; Chiti, Arturo; De Sanctis, Rita; Sollini, Martina; Antunovic, Lidija
Authors of the University:
CHITI ARTURO
SOLLINI MARTINA
Handle:
https://iris.unisr.it/handle/20.500.11768/187836
Full Text:
https://iris.unisr.it//retrieve/handle/20.500.11768/187836/326556/cancers-17-02133.pdf
Published in:
CANCERS
Journal
  • Overview

Overview

URL

https://www.mdpi.com/2072-6694/17/13/2133
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.11.1.0